A novel treatment of human malignant gliomas in vitro and in vivo

FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.

T. Komata, S. Koga, Satoshi Hirohata, M. Takakura, I. M. Germano, M. Inoue, S. Kyo, S. Kondo, Y. Kondo

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Telomerase activity has a close relationship with malignancies in many cell types and it is tightly regulated at the transcriptional level of human telomerase reverse transcriptase (hTERT). Utilizing the hTERT promoter, the authors developed a gene delivery system of Fas associated protein with death domain (FADD) (hTERT/FADD). FADD is a protein which plays an important role in the apoptotic pathway of Fas. Over-expression of FADD induces apoptosis in the cells regardless of Fas expression on the cell surface. We hypothesized that we might be able to restrict the expression of FADD in malignant glioma cells if we use the gene transfer system under the control of hTERT promoter. This study was designed to investigate whether the hTERT/FADD construct induces apoptosis effectively in malignant glioma cells while keeping normal cells intact. First, using the reverse transcription-polymerase chain reaction (RT-PCR) technique, we confirmed that hTERT mRNA was expressed in human malignant glioma cells (U373-MG, A172 and GB-1), but not in cultured astrocytes (TEN) or fibroblasts (MRC5). After transient transfection with the hTERT/FADD construct, a significant number of FADD-positive cells and apoptotic cells were detected in hTERT-positive malignant glioma cells. In contrast, hTERT-negative astrocytes and fibroblasts remained intact. Furthermore, subcutaneously implanted U373-MG tumors treated with the hTERT/FADD construct reduced in volume significantly compared to the conrol treatment (p=0.0001). Gene transfer of FADD under the control of the hTERT promoter may be a novel and promising therapy to kill hTERT-positive malignant glioma cells while sparing normal brain cells lacking hTERT.

Original languageEnglish
Pages (from-to)1015-1020
Number of pages6
JournalInternational Journal of Oncology
Volume19
Issue number5
Publication statusPublished - Nov 2001
Externally publishedYes

Fingerprint

Fas-Associated Death Domain Protein
Glioma
Genes
Astrocytes
human TERT protein
In Vitro Techniques
Fibroblasts
Apoptosis
Gene Transfer Techniques
Telomerase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A novel treatment of human malignant gliomas in vitro and in vivo : FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter. / Komata, T.; Koga, S.; Hirohata, Satoshi; Takakura, M.; Germano, I. M.; Inoue, M.; Kyo, S.; Kondo, S.; Kondo, Y.

In: International Journal of Oncology, Vol. 19, No. 5, 11.2001, p. 1015-1020.

Research output: Contribution to journalArticle

Komata, T. ; Koga, S. ; Hirohata, Satoshi ; Takakura, M. ; Germano, I. M. ; Inoue, M. ; Kyo, S. ; Kondo, S. ; Kondo, Y. / A novel treatment of human malignant gliomas in vitro and in vivo : FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter. In: International Journal of Oncology. 2001 ; Vol. 19, No. 5. pp. 1015-1020.
@article{c66f88a9b1ab4789b41c8fa156a721bb,
title = "A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.",
abstract = "Telomerase activity has a close relationship with malignancies in many cell types and it is tightly regulated at the transcriptional level of human telomerase reverse transcriptase (hTERT). Utilizing the hTERT promoter, the authors developed a gene delivery system of Fas associated protein with death domain (FADD) (hTERT/FADD). FADD is a protein which plays an important role in the apoptotic pathway of Fas. Over-expression of FADD induces apoptosis in the cells regardless of Fas expression on the cell surface. We hypothesized that we might be able to restrict the expression of FADD in malignant glioma cells if we use the gene transfer system under the control of hTERT promoter. This study was designed to investigate whether the hTERT/FADD construct induces apoptosis effectively in malignant glioma cells while keeping normal cells intact. First, using the reverse transcription-polymerase chain reaction (RT-PCR) technique, we confirmed that hTERT mRNA was expressed in human malignant glioma cells (U373-MG, A172 and GB-1), but not in cultured astrocytes (TEN) or fibroblasts (MRC5). After transient transfection with the hTERT/FADD construct, a significant number of FADD-positive cells and apoptotic cells were detected in hTERT-positive malignant glioma cells. In contrast, hTERT-negative astrocytes and fibroblasts remained intact. Furthermore, subcutaneously implanted U373-MG tumors treated with the hTERT/FADD construct reduced in volume significantly compared to the conrol treatment (p=0.0001). Gene transfer of FADD under the control of the hTERT promoter may be a novel and promising therapy to kill hTERT-positive malignant glioma cells while sparing normal brain cells lacking hTERT.",
author = "T. Komata and S. Koga and Satoshi Hirohata and M. Takakura and Germano, {I. M.} and M. Inoue and S. Kyo and S. Kondo and Y. Kondo",
year = "2001",
month = "11",
language = "English",
volume = "19",
pages = "1015--1020",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - A novel treatment of human malignant gliomas in vitro and in vivo

T2 - FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.

AU - Komata, T.

AU - Koga, S.

AU - Hirohata, Satoshi

AU - Takakura, M.

AU - Germano, I. M.

AU - Inoue, M.

AU - Kyo, S.

AU - Kondo, S.

AU - Kondo, Y.

PY - 2001/11

Y1 - 2001/11

N2 - Telomerase activity has a close relationship with malignancies in many cell types and it is tightly regulated at the transcriptional level of human telomerase reverse transcriptase (hTERT). Utilizing the hTERT promoter, the authors developed a gene delivery system of Fas associated protein with death domain (FADD) (hTERT/FADD). FADD is a protein which plays an important role in the apoptotic pathway of Fas. Over-expression of FADD induces apoptosis in the cells regardless of Fas expression on the cell surface. We hypothesized that we might be able to restrict the expression of FADD in malignant glioma cells if we use the gene transfer system under the control of hTERT promoter. This study was designed to investigate whether the hTERT/FADD construct induces apoptosis effectively in malignant glioma cells while keeping normal cells intact. First, using the reverse transcription-polymerase chain reaction (RT-PCR) technique, we confirmed that hTERT mRNA was expressed in human malignant glioma cells (U373-MG, A172 and GB-1), but not in cultured astrocytes (TEN) or fibroblasts (MRC5). After transient transfection with the hTERT/FADD construct, a significant number of FADD-positive cells and apoptotic cells were detected in hTERT-positive malignant glioma cells. In contrast, hTERT-negative astrocytes and fibroblasts remained intact. Furthermore, subcutaneously implanted U373-MG tumors treated with the hTERT/FADD construct reduced in volume significantly compared to the conrol treatment (p=0.0001). Gene transfer of FADD under the control of the hTERT promoter may be a novel and promising therapy to kill hTERT-positive malignant glioma cells while sparing normal brain cells lacking hTERT.

AB - Telomerase activity has a close relationship with malignancies in many cell types and it is tightly regulated at the transcriptional level of human telomerase reverse transcriptase (hTERT). Utilizing the hTERT promoter, the authors developed a gene delivery system of Fas associated protein with death domain (FADD) (hTERT/FADD). FADD is a protein which plays an important role in the apoptotic pathway of Fas. Over-expression of FADD induces apoptosis in the cells regardless of Fas expression on the cell surface. We hypothesized that we might be able to restrict the expression of FADD in malignant glioma cells if we use the gene transfer system under the control of hTERT promoter. This study was designed to investigate whether the hTERT/FADD construct induces apoptosis effectively in malignant glioma cells while keeping normal cells intact. First, using the reverse transcription-polymerase chain reaction (RT-PCR) technique, we confirmed that hTERT mRNA was expressed in human malignant glioma cells (U373-MG, A172 and GB-1), but not in cultured astrocytes (TEN) or fibroblasts (MRC5). After transient transfection with the hTERT/FADD construct, a significant number of FADD-positive cells and apoptotic cells were detected in hTERT-positive malignant glioma cells. In contrast, hTERT-negative astrocytes and fibroblasts remained intact. Furthermore, subcutaneously implanted U373-MG tumors treated with the hTERT/FADD construct reduced in volume significantly compared to the conrol treatment (p=0.0001). Gene transfer of FADD under the control of the hTERT promoter may be a novel and promising therapy to kill hTERT-positive malignant glioma cells while sparing normal brain cells lacking hTERT.

UR - http://www.scopus.com/inward/record.url?scp=0035515734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035515734&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 1015

EP - 1020

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -